How does metabolic surgery affect insulin sensitivity?

Question

Hello, Doctor,

I have been diagnosed with metabolic syndrome (high triglycerides, borderline A1C, and central obesity), and my doctor recommended I consider metabolic surgery, not just for weight loss, but to reset my metabolic pathways. I read that surgeries like Roux-en-Y gastric bypass change incretin hormones like GLP-1 (glucagon-like peptide 1) and GIP (gastric inhibitory polypeptide).

How exactly does this affect insulin sensitivity and fat metabolism?
Is there evidence that it reverses non-alcoholic fatty liver disease (NAFLD) or prediabetes in the long term?

I would appreciate real-world outcomes beyond just BMI reduction.

Kindly help.

Answer 1

Hello,

Welcome to icliniq.com.

I read your query and can understand your concern.

Metabolic surgery, such as Roux-en-Y gastric bypass, can indeed have profound effects on metabolic pathways. This surgery alters the secretion of incretin hormones like GLP-1 (glucagon-like peptide 1) and GIP (gastric inhibitory polypeptide), which play a crucial role in enhancing insulin sensitivity and regulating fat metabolism. These hormonal changes can lead to improved blood sugar control and reduced fat storage.

There is evidence suggesting that Roux-en-Y gastric bypass can help reverse Non-alcoholic fatty liver disease (NAFLD) and prediabetes in the long term. Many patients experience significant improvements in liver function and glucose metabolism, along with sustained weight loss.

Real-world outcomes often show improvements in overall metabolic health, beyond just BMI reduction. Patients typically see better blood sugar levels, cholesterol profiles, and reduced risk of cardiovascular diseases.

I hope this helps.

Thank you.